RSV vaccines have reportedly fallen since U.S. regulators narrowed the recommended age range and frequency for the shots.

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

You can find plenty of affordable stocks that offer solid long-term growth prospects. If you're interested in the healthcare ...

Pfizer has reportedly ended its Phase II/III trials for sisunatovir, a promising RSV candidate acquired with ReViral in a ...

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

Pfizer Inc. (NYSE:PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is scheduled to meet with executives from activist hedge fund Starboard Value next week. The news ...

Bourla and Shantanu Narayen, Pfizer's lead independent director and Adobe Systems CEO, will hold talks with Starboard chief ...

Pfizer to present data across respiratory and other infectious diseases portfolio at IDWeek 2024 congress: New York Thursday, October 10, 2024, 09:00 Hrs [IST] Pfizer Inc. will pr ...

Presentations highlight momentum of Pfizer's portfolio of infectious disease prevention and treatment options NEW YORK, October 8, 2024 - Pfizer Inc ...

At the 40-year anniversary of Ghostbusters, Ernie Hudson shares something Americans should gear up to fight this season—with ...

The prescription-free test you can take at home will help discern which respiratory virus you have, as symptoms often overlap ...

The protection also held across different strains, for people in their 70s, and for those with underlying medical conditions.